GSK Not Immune To Drug-Discount Antitrust Suit, Clinic Says

Law360, New York (February 27, 2013, 6:53 PM EST) -- A specialty health clinic urged a Nevada federal judge on Tuesday not to shield GlaxoSmithKline LLC from allegations it engaged in illegal price discrimination by selling lower-cost vaccines to select medical providers, accusing the drugmaker of falsely pretending its conduct is endorsed by the federal government.

The Vaccine Center and Travel Medicine Clinic in Las Vegas, which sued U.K.-based GSK in October for alleged violations of the Robinson-Patman Act, says the company wrongly believes it’s entitled to immunity for disparate pricing under the so-called 340B program...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.